Zibo Qidingli Patent Information Consulting Co., Ltd., established on 2013-06-03, Business scope includes patent technology consulting,to develop,to promote;advertisement plan(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**

Nitec is a specialty pharmaceutical company focused on the commercialization and development of medicines to treat chronic inflammation and pain-related diseases. It seeks to address areas of high unmet medical need within these markets by developing proprietary products based on well-characterized pharmaceuticals and disease targets. The Company is a spin-out of Merck KGaA and is headquartered in the Basel region of Switzerland. Since its formation in 2004, Nitec has developed and commercialized its lead product, Lodotraâ„¢. Nitecâ€:tm:s most advanced product candidate is Lodotraâ„¢, a circadian cytokine modulator, which successfully completed a European phase 3 trial in rheumatoid arthritis (RA) in 2006. In January 2009, Lodotraâ„¢ was recommended for European regulatory approval for the treatment of rheumatoid arthritis (“RA”), particularly the associated and debilitating morning stiffness, following the successful completion of a phase III trial (CAPRA-1) in 2006. Germany was the Reference Member State and Lodotraâ„¢ is now also expected approvable by the regulatory agencies of 14 other countries under the Decentralized Procedure. In March Nitec announced a European partnership for Lodotraâ€:tm:s commercialization with MundiPharma. Merck KGaA, which holds the distribution rights to Lodotraâ„¢ in Germany and Austria, have recently launched the product in Germany. Nitec is conducting a second pivotal phase 3 trial in preparation for the filing of an NDA with the FDA seeking US approval of Lodotraâ„¢ for the treatment of the signs and symptoms of RA including morning stiffness. Lodotraâ„¢ is also being developed for the treatment of severe asthma and polymyalgia rheumatica (PMR). Nitecâ€:tm:s second product candidate is TruNocâ„¢ (tarenflurbil), which is being developed as a treatment of neuropathic pain and other chronic inflammation and pain-related diseases. Nitec is conducting pharmacokinetic studies in preparation for phase 2 trials in neuropathic pain.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Shanghai Maibu Pharmaceutical Technology Co., Ltd., established on 2013-09-03, Business scope includes medical technology,biomedicine,Technology development in the field of environmental protection technology,technology transfer,technical consulting,Chemical raw materials and products(In addition to monitoring chemicals,Hazardous Chemicals,precursor chemicals,firecrackers,civilian explosives),Sales of equipment,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Rudong Wenyuan Investment and Development Co., Ltd., established on 2011-12-26, Business scope includes licensed projects:Construction Engineering Construction;Construction Project Supervision(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Engage in investment activities with own funds;property management;Information Consulting Service(Not including licensing information consulting services);Municipal facilities management;Sales of building materials(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Manufactures and markets pharmaceutical preparations and other medical products

Guangzhou Bocui Medical Laboratory Technology Co., Ltd., established on 2013-12-06, Business scope includes medical research and experimental development;Biotechnology Consulting,communication service;Scientific and technological achievements appraisal service;Biotechnology Development Services;Biotechnology Extension Services;Biotechnology Transfer Services;medical diagnosis,Monitoring and treatment equipment manufacturing;

Stagen Co., Ltd. provides data analysis in drug discovery. It offers new drug development, healthcare information and communications technology business, educational projects on statistical genetics and genome-based new drug development, clinical research supporting business, support for genome-wide association study, support for clinical trials including genome information, analysis of data from next generation sequencers, support for genomic studies in animals and plants, and intellectual properties. The company was founded in October 1999 and is headquartered in Tokyo, Japan.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France.

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs. It seeks to solve challenges in health with science, to help people live healthier and longer lives. It works directly with the scientists, clinicians, and health professionals around the world to identify and develop the natural compounds. Its product is a proprietary formulation of two ingredients designed to support long-term well-being at the cellular level.

Guangdong General Hospital (Chinese: 广东省人民医院 meaning "Guangdong Provincial People's Hospital") is a large hospital, founded in 1946, located in Yuexiu District, Guangzhou, Guangdong, China.

ALTANA Pharma AG develops and manufactures pharmaceuticals. It provides services in the areas of therapeutics, imaging and OTC medication. The company is headquartered in Konstanz, Germany.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation of new blood vessels, is a characteristic feature of many severe pathologies such as cancer, rheumatoid arthritis, and age-related macular degeneration. The company has been a pioneer in the isolation, engineering and clinical development of lead products capable of targeting angiogenesis in-vivo and has been the first in the world to demonstrate that human monoclonal antibodies, specific for a marker of angiogenesis, can efficiently and selectively target the tumor neo-vasculature both in animal models and in cancer patients. At present, Philogen has four promising anti-cancer antibody derivatives and an antibody derivative for the treatment of rheumatoid arthritis in clinical studies. Two registrational studies are in planning. Our Zurich-based daughter company Philochem serving as the R&D unit isolates the most promising candidate products, while in Siena (Italy) the pharmaceuticals are produced according to GMP standards and advanced to clinical trials. Philogen generates revenue from a diversified range of activities, has signed agreements with major pharmaceutical companies and owns a diversified portfolio of international patents.

SmithKline Beecham (Cork) Ltd., part of GSK Plc, is an Irish company located in Carrigaline that manufactures pharmaceutical products.

KaloBios Pharmaceuticals provides medicines for respiratory diseases and certain cancers. The company is a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases. They designed to overcome marketed antibody products.

Beijing Jishuitan Hospital (JST Hospital; simplified Chinese: 北京积水潭医院; traditional Chinese: 北京積水潭醫院), is a large-scaled first-level hospital in Beijing, focusing mainly on orthopaedics and burn surgery. Founded in 1956, the hospital now has around 1000 beds. Its performance in medical care, teaching and researching led to it becoming the Fourth Medical College of Peking University. The hospital now has 200 doctors and 2200 other staff. The hospital has fully equipped departments of orthopaedics, spine surgery, adult joint reconstructive surgery, orthopaedic trauma, hand surgery, paediatric orthopaedics, bone tumor, sports medicines and burn surgery.